Evaluating Stress Management Among Allogeneic HCT Caregivers
- Conditions
- BurdenStress
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 540
Inclusion Criteria:<br><br> - Caregiver Inclusion Criteria:<br><br> - Caring for a patient planning to receive an allogeneic HCT at Moffitt<br><br> - Intending to remain primary caregiver throughout patient treatment (i.e., will be<br> the caregiver the majority of the time)<br><br> - Able to provide informed consent<br><br> - Able to read and write in English<br><br> - Owns a smartphone and is willing to download the study app<br><br> - Patient Inclusion Criteria:<br><br> - Receiving an allogeneic HCT at the cancer center<br><br> - Able to provide informed consent<br><br> - Able to read and write in English<br><br>Exclusion Criteria:<br><br> - Under 21 years of age<br><br> - Unable to provide informed consent<br><br> - Unable to read and write in English<br><br> - Caregiver is unable to remain primary caregiver throughout patient treatment<br><br> - Patient does not receive transplant at Moffitt Cancer Center
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Caregiver Burden at End of Treatment;Caregiver Burden at 2 Month Follow-up;Caregiver Burden at 6 Month Follow-up;Patient Distress at End of Treatment (CESD);Patient Distress at End of Treatment (GAD-7);Patient Distress at 2 Month Follow-up (CESD);Patient Distress at 2 Month Follow-up (GAD-7);Patient Distress at 6 Month Follow-up (CESD);Patient Distress at 6 Month Follow-up (GAD-7)
- Secondary Outcome Measures
Name Time Method Patient Healthcare Utilization - Readmissions to the hospital at 6 Month Follow-up;Patient Healthcare Utilization - unexpected clinic visits post discharge at 6 Month Follow-up